GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daan Gene Co Ltd (SZSE:002030) » Definitions » Interest Coverage

Daan Gene Co (SZSE:002030) Interest Coverage : 0 (At Loss) (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Daan Gene Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Daan Gene Co's Operating Income for the three months ended in Mar. 2025 was ¥-67.4 Mil. Daan Gene Co's Interest Expense for the three months ended in Mar. 2025 was ¥-1.2 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Daan Gene Co's Interest Coverage or its related term are showing as below:


SZSE:002030's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 113.1
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Daan Gene Co Interest Coverage Historical Data

The historical data trend for Daan Gene Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Daan Gene Co Interest Coverage Chart

Daan Gene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 120.00 439.16 489.40 5.67 -

Daan Gene Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Daan Gene Co's Interest Coverage

For the Biotechnology subindustry, Daan Gene Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daan Gene Co's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Daan Gene Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Daan Gene Co's Interest Coverage falls into.


;
;

Daan Gene Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Daan Gene Co's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Daan Gene Co's Interest Expense was ¥-9.7 Mil. Its Operating Income was ¥-229.3 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥13.5 Mil.

Daan Gene Co did not have earnings to cover the interest expense.

Daan Gene Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Daan Gene Co's Interest Expense was ¥-1.2 Mil. Its Operating Income was ¥-67.4 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥13.5 Mil.

Daan Gene Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Daan Gene Co  (SZSE:002030) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Daan Gene Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of Daan Gene Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Daan Gene Co Business Description

Traded in Other Exchanges
N/A
Address
No.19 Xiangshan Road, Science Park, High & New Technology Development District, Guangdong, Guangzhou, CHN, 510665
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
Executives
Zhou Xin Yu Directors, executives
He Yun Shao Director
Huang Ru Hui Supervisors
Cheng Gang Directors, executives
Xu Qing Supervisors
He Li Xin Supervisors

Daan Gene Co Headlines

No Headlines